 There is a nearly identical multi-site trial NCT00702819 currently recruiting, which Childrens Hospital Los Angeles is a part of. However, that study has limiting enrollment criteria; this compassionate-use study was created to provide access to bevacizumab Avastin for high-risk infants who do not qualify for study NCT00702819. 